Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Jnj crawled date : 2021 - 11 - 01 save search
Janssen Announces Extension of U.S. FDA BLA PDUFA Date for BCMA CAR-T Ciltacabtagene Autoleucel
Published: 2021-11-01 (Crawled : 21:00) - prnewswire.com
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.26%
H: 2.0%
C: 1.15%
fda pdufa car-t
BioVie Announces the Appointment of a New Chief Medical OfficerDr. Joseph M. Palumbo, Distinguished Pharma Industry Veteran, to Oversee Development Programs in Neurodegenerative and Liver Disease
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 3.72%
H: 0.0%
C: 0.0%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.79%
H: 1.18%
C: 0.92%
BIVI | News | $0.4931 0.96% 330K
|
Health Technology
|
| O: 1.47%
H: 8.86%
C: 6.28%
disease liver disease neurodegenerative liver
New Book Release: Discover Please Pass The Tort$ - A Comic Novel Written By The Dean Of False Advertising Law On Shelves Today
Published: 2021-11-01 (Crawled : 15:15) - prnewswire.com
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
oda
New Phase 3 First-in-Class TREMFYA® (guselkumab) Data Show Durability of Joint Efficacy, Including Low Rates of Structural Damage Progression, and a Demonstrated Safety Profile in Adults with Active Psoriatic Arthritis (PsA)
Published: 2021-11-01 (Crawled : 14:15) - prnewswire.com
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
phase 3
New Comprehensive Phase 3 Data Show First-in-Class TREMFYA® (guselkumab) Provided Durable Improvements in Measures of Psoriatic Arthritis (PsA) Disease Activity Through Two Years
Published: 2021-11-01 (Crawled : 12:00) - prnewswire.com
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
disease phase 3
Esperion Announces the Appointment of Seth H.Z. Fischer to its Board of Directors
Published: 2021-11-01 (Crawled : 11:00) - globenewswire.com
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 0.27%
H: 6.81%
C: 5.18%
ESPR | $1.82 -2.67% 3M
|
Health Technology
|
| O: -1.34%
H: 0.0%
C: 0.0%
BSGM | $1.44 -6.49% 110K
|
Health Technology
|
| O: 0.37%
H: 34.69%
C: 19.93%
AGRX | $0.37 15K
|
Health Technology
|
| O: -1.28%
H: 6.86%
C: 3.44%
Essity acquires sports tape brands from Johnson & Johnson Consumer Inc.
Published: 2021-11-01 (Crawled : 08:00) - prnewswire.com
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
brands
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
NVFY | $3.45 63.51% 20M
|
Consumer Durables
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.